Controlling drug delivery kinetics from mesoporous titania thin films by pore size and surface energy
Artikel i vetenskaplig tidskrift, 2015

The osseointegration capacity of bone-anchoring implants can be improved by the use of drugs that are administrated by an inbuilt drug delivery system. However, to attain superior control of drug delivery and to have the ability to administer drugs of varying size, including proteins, further material development of drug carriers is needed. Mesoporous materials have shown great potential in drug delivery applications to provide and maintain a drug concentration within the therapeutic window for the desired period of time. Moreover, drug delivery from coatings consisting of mesoporous titania has shown to be promising to improve healing of bone-anchoring implants. Here we report on how the delivery of an osteoporosis drug, alendronate, can be controlled by altering pore size and surface energy of mesoporous titania thin films. The pore size was varied from 3.4 nm to 7.2 nm by the use of different structure-directing templates and addition of a swelling agent. The surface energy was also altered by grafting dimethylsilane to the pore walls. The drug uptake and release profiles were monitored in situ using quartz crystal microbalance with dissipation (QCM-D) and it was shown that both pore size and surface energy had a profound effect on both the adsorption and release kinetics of alendronate. The QCM-D data provided evidence that the drug delivery from mesoporous titania films is controlled by a binding-diffusion mechanism. The yielded knowledge of release kinetics is crucial in order to improve the in vivo tissue response associated to therapeutic treatments.

mesoporous titania

alendronate

QCM-D

release kinetics

controlled drug delivery

Författare

Johan Karlsson

Chalmers, Kemi och kemiteknik, Tillämpad kemi, Teknisk ytkemi

Saba Atefyekta

Chalmers, Kemi och kemiteknik, Tillämpad kemi, Teknisk ytkemi

Martin Andersson

Chalmers, Kemi och kemiteknik, Tillämpad kemi, Teknisk ytkemi

International journal of nanomedicine

1176-9114 (ISSN) 1178-2013 (eISSN)

Vol. 10 4425-4436

Ämneskategorier

Farmaceutisk synteskemi

DOI

10.2147/IJN.S83005